Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T23:29:05.522Z Has data issue: false hasContentIssue false

Enterprise risk management for health insurance from an actuarial perspective

Published online by Cambridge University Press:  13 March 2012

Rights & Permissions [Opens in a new window]

Abstract

This paper focuses on Enterprise Risk Management (ERM) and strategic business management for health insurance companies in our world of ‘unknown unknowns’ and the emergence of unexpected risks over time. It illustrates how Chief Risk Officers (CROs) can focus on ‘risk and opportunity management’ through an ERM framework, and thereby balance risks against opportunities, whilst being resilient against ‘unknown unknowns’ and their emergence over time as ‘known unknowns’ and ‘known knowns’. The paper has been designed to meet the broad requirements of health insurers that would like to implement an ERM framework for the effective risk management of their health insurance lines of business. Risk management for health insurers in the context of Solvency II and broader European Commission regulatory requirements is also discussed. The authors discuss how insurers can develop and apply risk management to build resilience in the face of the storms and shocks that may lie ahead.

Information

Type
Sessional meetings: papers and abstracts of discussions
Copyright
Copyright © Institute and Faculty of Actuaries 2012
Figure 0

Figure 1COSO ERM Framework

Figure 1

Figure 2Risk appetite expressed as a risk map

Figure 2

Figure 3Principle and effects of specific business plan revisions

Figure 3

Figure 4Strategic Risk Management Pillars

Figure 4

Figure 5ERM Board FunctionsSource: Adapted from Garratt (2003).

Figure 5

Figure 6Overview of Chapman (2006) ERM Corporate Governance Model

Figure 6

Figure 7Chapman (2006) 6-stage ERM process

Figure 7

Figure 8IDEFO Process Mapping Technique

Figure 8

Figure 9Typical process map for ERM analysis stage

Figure 9

Figure 10Value chain for a health insurer

Figure 10

Figure 11Typical process map for the ‘Risk Identification’ stage

Figure 11

Figure 12Risk Register – Stage 2: Risk Identification

Figure 12

Figure 13Typical process map for the ‘Risk Assessment’ stage

Figure 13

Figure 14High Level Risk Map

Figure 14

Figure 15Typical Risk Heat Map

Figure 15

Figure 16Example of a Risk Heat Map for a large multi national insurance group

Figure 16

Figure 17Typical process map for ‘Risk Evaluation’ stage

Figure 17

Figure 18Typical Process Map for ‘Risk Planning’ Stage

Figure 18

Figure 19Typical example of Traffic Lights Confidence Test for Health Insurers

Figure 19

Figure 20Typical process map for ‘Risk Management’ stage

Figure 20

Figure 21Typical internal sources of risk

Figure 21

Figure 22Typical external sources of risk

Figure 22

Figure 23‘Key performance indicators’ for health insurers

Figure 23

Figure 24The Impact of the Highly ImprobableSource: Taleb (2007)

Figure 24

Figure 25Risk Matrix Model illustrating the probability of failure

Figure 25

Figure 26Risk Matrix Model, indicating probability of failure and the innovation portfolio

Figure 26

Figure 27Illustration of a typical scoring matrix

Figure 27

Figure 28Typical ‘Product/Service/Technology scoring template

Figure 28

Figure 29Typical R-W-W Screening Programme

Figure 29

Figure 30Risk Profile – Executive SummaryNotes:The top 12 risks have been positioned on the risk matrix and it is important to show their ‘before’ and ‘after’ situation, where the ‘after’ situation represents the indicated ‘inherent residual risk’ position. Any risks coloured ‘red’ (e.g. Risks 7, 11 and 12) are in the extreme danger zone and need remedial action (e.g. termination of underlying risk, as their implied risk tolerance is unacceptable). Any risks coloured ‘orange’ (e.g. Risks 6 and 10) are in the severe danger zone and need remedial action (e.g. business plan to move to a reduced underlying risk assessment). Any risks coloured ‘green’ (e.g. Risk 2) may be too safe and consideration should be given to divestment to another organisation that can create more added value. In practice, the management team will need to focus primarily on the ‘severe’ and ‘extreme’ zones and satisfy themselves that appropriate remedial action is taken, as these risk assessments are unsustainable.

Figure 30

Figure 31Interaction and flow of fundsSource: Foubister et al. (2006)Notes:In Figure 31, private hospitals and specialists have been boxed separately, since the initial consultation and the hospital treatment is separated in time and place. Moreover, a privately financed consultation may not necessarily lead to a hospital episode. The consultation will often take place in office space that does not belong to a private hospital and for which the specialist will pay rent or a fee.

Figure 31

Figure 32Public Sector Perspective of Decisions

Figure 32

Figure 33Best Practice Standards for Clinical Governance and Quality ImprovementSource: Scally & Donaldson (1998)

Figure 33

Figure 34Summary of Health ModulesSource: CEIOPS (2010a)

Figure 34

Figure 35Recommended Factors for Premium and Reserve Risk Sub ModulesSource: CEIOPS (2010a)Note:CEIOPS has recommended an adjustment factor for Premium Risk that is undertaking specific, and so it is not possible to provide a single numeric net premium factor common for all insurers since the effect of reinsurance uniquely affects each insurer. NCR and GCR stand for net combined ratio and gross combined ratio respectively

Figure 35

Figure 36Distribution of annual claims, assuming an estimation error of 99.55 VAR

Figure 36

Figure 37Capital charge for combined premium risk and reserve risk

Figure 37

Figure 38Calibration of key parameters of the Standard Formula for the SCR and the calculation of technical provisions for the purpose of QIS-5 in the final advice for CP 72

Figure 38

Figure 39Summary of draft technical factors for the QIS-5 calibration for the non-SLT health underwriting module for the Standard Formula

Figure 39

Figure 40Summary of non-SLT health underwriting risk module - development of premium factorsNote:The adjustment factor for non-proportional reinsurance NP by line of business allows undertakings to take into account the risk-mitigating effect of particular per risk excess of loss reinsurance.

Figure 40

Figure 41Summary of non-SLT health underwriting risk module - development of reserve factors

Figure 41

Figure 42Fluctuation of a health insurance portfolio's dynamics through turbulent macro-economic context